Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tempramed Technologies Ltd. (VIVI.CN)

Tempramed Technologies Ltd. (VIVI.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 76,947
  • Shares Outstanding, K 76,947
  • Annual Sales, $ 2,270 K
  • Annual Income, $ -19,177 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales 28.50
  • Price/Cash Flow N/A
  • Price/Book N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8500 +29.41%
on 01/13/26
1.4000 -21.43%
on 01/05/26
-0.2000 (-15.38%)
since 01/02/26
3-Month
0.7000 +57.14%
on 12/19/25
1.4000 -21.43%
on 01/05/26
+0.2000 (+22.22%)
since 10/31/25

Most Recent Stories

More News
TempraMed is Revolutionizing Storage of Life-Saving Medication: a $30 Billion Market Opportunity

TempraMed Technologies is scaling its FDA-registered, space-grade thermal storage solutions for temperature-sensitive medications like insulin, projected to reach $19 million in revenue by 20

VIVI.CN : 1.1000 (+10.00%)
TempraMed Enters Strategic Media Partnership with Dr. Phil's Envoy Media, Validating Product Portfolio and Accelerating Market Adoption Across the United States

Access to an audience of over 19 million individuals monthly will expand national exposure, and supports scalable demand generation across B2C and B2B channels for TempraMed's full product portfolioVancouver,...

VIVI.CN : 1.1000 (+10.00%)
TempraMed Launches New Product "VIVI Med(TM)," Unlocking New Growth Opportunities in High-Value Biologics and Injectable Medications

Using same proprietary, patented technology, VIVI Med extends the product portfolio beyond injectable pens, opening access to broader patient populations, premium biologics, and institutional channelsHighlightsUses...

VIVI.CN : 1.1000 (+10.00%)
TempraMed Receives Positive Response on Payor Reimbursement Model Driving Significant Return on Investment for Medical Payor Coverage

Validation is expected to accelerate TempraMed's path to payor reimbursement for product portfolioHighlightsROI model validated for savings and metrics by Validation Institute, a leading authority in healthcare...

VIVI.CN : 1.1000 (+10.00%)
TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"), a medical-technology innovator transforming how temperature-sensitive...

VIVI.CN : 1.1000 (+10.00%)
TempraMed Receives First Commercial Order from Israel Distributor and Completes Initial Shipment Enabling Entry into National Pharmacy Network

Initial shipment delivered to distributor warehouse supports expansion into B2B pharmacy distribution alongside direct-to-consumer activitiesVancouver, British Columbia--(Newsfile Corp. - January 6, 2026)...

VIVI.CN : 1.1000 (+10.00%)
TempraMed Provides Positive Recap on 2025 and Strategic Outlook for 2026

Vancouver, British Columbia--(Newsfile Corp. - January 2, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE: 9DY) ("TempraMed" or the "Company"), a medical technology innovator transforming how temperature-sensitive...

VIVI.CN : 1.1000 (+10.00%)
TempraMed Deepens Asian Market Penetration with Expanded Distribution Partnership and Meaningful Commercial Order in South Korea

Expansion builds on newly granted South Korean patent, rising local demand and following the launch of digitally connected "VIVI Cap Smart" deviceVancouver, British Columbia--(Newsfile Corp. - December...

VIVI.CN : 1.1000 (+10.00%)
TempraMed Launches New Product, VIVI Cap Smart, Expanding Its Portfolio to Include a Digital Health Offering

Integrated smart technology builds on TempraMed's proven VIVI platform, providing robust Temperature control with medication management for individuals using life-saving medicationHighlights: Expands TempraMed's...

VIVI.CN : 1.1000 (+10.00%)
TempraMed Expands U.S. Manufacturing Capacity with New Production Facility in Florida

New facility increases output, reduces cost of goods sold (COGS) and enhances service for B2B customers to address the forecasted increased demand for productsHighlights: Manufacturing site in Florida...

VIVI.CN : 1.1000 (+10.00%)

Business Summary

TempraMed Technologies Ltd develops patent-protected solutions for managing and protecting temperature-sensitive medications. Its product range includes VIVI Cap for insulin pens and VIVI Epi for epinephrine injectors, which are distributed through pharmacy and retail networks globally. TempraMed generates...

See More

Key Turning Points

3rd Resistance Point 1.3000
2nd Resistance Point 1.2200
1st Resistance Point 1.1600
Last Price 1.1000
1st Support Level 1.0200
2nd Support Level 0.9400
3rd Support Level 0.8800

See More

52-Week High 1.4000
Fibonacci 61.8% 1.1326
Last Price 1.1000
Fibonacci 50% 1.0500
Fibonacci 38.2% 0.9674
52-Week Low 0.7000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar